Related Experiment Video
Updated: Sep 14, 2026
Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
No evidence of developmental III effects of low-level lead exposure in a developing country
A W Wolf1, E Jimenez, B Lozoff
1Department of Psychiatry, Case Western Reserve University, School of Medicine, MetroHealth Medical Center, Cleveland, Ohio.
Insights
This study found no adverse neurodevelopmental effects in healthy toddlers with low blood lead levels. Lead exposure in infancy did not impact cognitive or psychomotor development at age five.
Area of Science:
- Environmental Health
- Pediatric Neurodevelopment
- Toxicology
Background:
- Controversy exists regarding blood lead levels affecting neurobehavioral development.
- Public health policies increasingly recommend stringent lead screening criteria.
- Late infancy is a key period for surveillance due to developmental vulnerability.
Purpose of the Study:
- To investigate the effects of low blood lead levels on neurodevelopment in infants and toddlers.
- To assess developmental outcomes in a population with a mean blood lead level of 11.0 µg/dL.
- To inform public health policy on lead exposure surveillance.
Main Methods:
- A community-based study in Costa Rica involving 184 healthy infants and toddlers (12-23 months old).
- Assessment of infant blood lead levels (mean 11.0 µg/dL, range 5.4–37.0 µg/dL).
- Developmental evaluation using Bayley Scales of Infant Development and reevaluation at age five with physical and psychological testing.
Main Results:
- Infant blood lead levels were not associated with the Mental or Psychomotor Developmental Index.
- Childhood blood lead levels did not predict any developmental outcome measures at age five.
- No adverse developmental effects were observed in healthy toddlers with low blood lead levels.
Conclusions:
- Low blood lead levels in healthy toddlers from a developing country were not linked to adverse neurodevelopmental outcomes.
- Findings suggest current stringent screening criteria may not be warranted for this population.
- Further research is needed to understand lead's impact across diverse populations and exposure levels.
Abstract:
Despite substantial controversy regarding the blood levels at which lead adversely affects neurobehavioral development, public health policy in some industrialized countries is prescribing ever more stringent screening criteria for all ages. This study addressed the question of ill effects of lead exposure at the new lower levels, specifically during the late infancy period, which has been targeted for maximum surveillance in pediatric practice. The sample of 184 participants consisted of 12- to 23-month-old healthy infants and toddlers who participated in a community-based study in a developing Central American country (Costa Rica) where extensive family and developmental information was collected. The mean infant blood lead level was 11.0 micrograms/dL, ranging from 5.4 to 37.0 micrograms/dL. Lead levels were not related to the Mental or Psychomotor Developmental Index of the Bayley Scales of Infant Development. When the children were 5 years old, they were reevaluated with complete physical and psychological testing. Blood lead levels in infancy did not predict any of the developmental outcome measures. Thus, among a group of healthy toddlers in a developing country, no ill effects on development of low blood lead levels were observed.
Related Concept Videos
01:23Toxicity Testing in Animals
01:29Environmental Influences on Intelligence
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.